A Study of LY900014 and Insulin Degludec in Participants With Type 1 Diabetes
Clinical trial NCT04585776 · COMPLETED
Trial details
- NCT number
- NCT04585776
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-30
- Primary completion
- 2021-05-27
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.